We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Myhealthchecked Plc | MHC | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 12.00 | 08:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 12.00 | 12.00 | 12.00 | 12.00 | 12.00 |
| Industry Sector |
|---|
| HEALTH CARE EQUIPMENT & SERVICES |
| Top Posts |
|---|
Posted at 16/10/2024 09:54 by tia01 The Poc Doc agreement is to start in 2025 isn’t it!.On another note how many times will it try and break 15p. Every time it tries it pulls back a little. Once selling price hits 15p I think it will create new investors FOMO. Especially if news lands |
Posted at 06/10/2024 08:20 by tia01 The simple 50DMA @11.26p about to cross the 200 DMA @ 11.31p!Is this important and why! In my opinion it is vital because after a recent pullback from over 15p it could be the Golden Cross required to push it forward to higher highs. One ca not always rely on a golden cross however if any news lands in the coming week we could easily see momentum returning and pushing it back into the 20s. I totally believe Donald Hamilton is a serious investor who placed in buys at a critical point in the journey and unceasing his stake from 1.5% to over 6% is a signal something about to happen. The fact the Market cap is 6m and 6m in cash in the bank is a clear indicator that the markets are ignoring the great financial control the board has demonstrated whist growing with new deals such as pharmacy2U and poc doc. The digital investment. Is Donald Hamilton the digital marketing expert on linked in!. MHC has no shorts and investors increasing holdings!. How many AIM companies in this position! Will MHC become the go to place for the future of the NHS along with Boots!. Is Penny about to deliver a revenue breaking update with Boots deal!. The signs of a breakout are in place however note we must see the Golden cross trigger as a buying signal so watch for a sudden jump once the Golden cross is confirmed for guidance. Good luck and remember no believed in crypto at $1 and now it $60,000. Time to get greedy and place you long term bets!!!!! |
Posted at 03/10/2024 10:01 by pavey ark From MERCIA:"As the Board looks to the future, and refreshes its three-year strategic plan, Mercia's intention is to focus much more on our profitable and fast-growing FuM. Our intention therefore is no longer to make new direct investments from our balance sheet. We will continue to support our existing direct investments, but anticipate that their number will reduce as these investments are realised." MHC is small change for MERC but they own or control over 26% with another fund controlling over 8%. If this 6% guy wants the company he is now negotiating a price that is acceptable to the two holders with a total of 35% of the company. Obviously something is only worth what someone will pay for it but I would suggest that most private investors would take c.25p and head for the door. On a personal note my break even is 13.5p ....having doubled up in early June. I was looking to get out at not much above 15p but I think I'll wait and see how things go. |
Posted at 03/10/2024 06:43 by keithadaz Agreed the board is a third of the'action' , although it doesnt act like it controls that amount, which i why I posted. The future appears to be what serious investors do. A mate once said that noone takes 5% of a company without wanting and planning on another 45.1 % [ his dad was CFO of a $30bn PLC and had told him ] . I havent much knowledge of VC funds especially thosee who use SEIS and EIS , but once MHC proves their teechnology, Mercia will be looking for an exit . A fund owning 30% and a company taking a notifiable stake doesnt sound like a coincidence .... |
Posted at 26/9/2024 21:16 by tia01 hxxps://investors.myA great professional presentation from Penny. I mentioned Poc Doc months ago as a possible collaboration so happy we are on board. The digital investment will pay off however we need time. Revenue fall was expected although 3m advanced COVID test orders a nice bonus. As the brand grows Penny also expects the 20% margins to grow. Clearly focused on Boots so expect the news on that front at some point. Cost control been instrumental. Pharmacy 2u deal a little beauty really. Since June Covid has picked up. Covid sales showing 24% decline year on year which suggests strong revenue second half as new variants take hold. Penny seems extremely confident of her market being 2/3 women and 1/3 men. Also able to use data to target age groups!. Definitely in growth phase but given we are still self funded and debt free with a potential 1.67m VAT return claim possible we are definitely in a strong position moving forward. However market reaction wasn’t kind and we need to find support before a potential bounce. A hold above the 200DMA would be excellent. Let’s hope analysts get behind MHC and can see what value pod doc and pharmacy2U can add second half. Plus remember we are moving into more Boots branches and possibly phlebotomy testing coming soon which will definitely enhance sales and pave the way for government to realise the benefits rather than over load a stretched GP service struggling as Penny alerted us to. Short term anything possible but long term very positive news coming from MHC |
Posted at 10/9/2024 15:25 by muck166 Honestly Tia, I have no idea.I'm not at all surprised about the continuing low volume though. The company shares very very little information to alert or excite retail investors - you only have to look at the BB's to see the lack of any investor engagement. |
Posted at 27/8/2024 11:32 by muck166 Tia - I don't want to get in a spat with you about valuations, especially on the MHC board. And I am not saying MHC is a bad company - it isn't.Yes, ABDX supplies Boots with some own label tests. In fact, they are exactly the same Chinese tests that MHC also sell through Boots, just in different packaging. And yes, ABDX makes and sells pregnancy tests, as well as other tests. But even a cursory look at its accounts will show you that revenue it makes from total product sales is less than 10% of its total revenue. The bulk of its revenue comes from CDMO/CRO activities on a fee for service model, ie it helps third party lateral flow developers move an idea to a commercial, approved LFT product that can be manufactured at scale and robustly. That is its main business, and its NOT the same as MHC. I don't know why MHC has an MCAP of less than ABDX, but if I were to guess I would say it's because MHC remains heavily reliant on COVID revenue (which is falling) and seems to be stagnating rather than growing, whereas ABDX has growing revenue from a multitude of different customers and streams, as well as some huge potential in its pipe. There are very good reasons why 3 institutional investors took almost all of the recent raise at less than a 10% discount - I assume it's because they see real growth potential in ABDX. Sadly, MHC isn't showing investors anything at the moment. |
Posted at 18/7/2024 11:52 by tia01 Personally I think Covid Revenue is and has been hugely valuable otherwise it would have been a disaster with dilution.The key is what the plans are with Boots and MHC 100%. Penny clearly has briefed us on a deal in recent months at the investor meeting. However until this is clarified and relayed to the market I guess nothing will happen. I also guess given they are in talks with Boots it’s clear Directors can not buy any to support the share price. Either way I believe many investors heavily down and totally confused by the lengthy time it’s taken for any news which is why price keeps drifting lower. Do I personally feel the price is way undervalued!. 100% News needed urgently as investors are losing patience and moving on. That could be a mistake as News definitely imminent. |
Posted at 04/6/2024 16:30 by tia01 Listening was interesting and it would appear they are working on a few things which Penny said they intend to share with the market over coming months!. Maybe one reason they can’t buy shares if they have price sensitive information.Seems like B2B with insurance is area of potential growth. Still happy with cash position penny says and self sufficient. I bet if share rose suddenly we could see and acquisition and capital raise. Not quite what to make when asked about ABDX. LFT tests never seemed to be her main focus. Nothing said from Chairman. Honestly I can’t believe how low share price is on cash alone compared to competitors and their positions financially and market caps out there. Maybe this may change and they may get some credit for being self sufficient and not needing to dilute over the years. Most investors bailed already after huge losses and I don’t believe any investors making any capital return on investment so far. Far to say you must believe share price can go use from these levels but who knows |
Posted at 11/5/2024 09:35 by tia01 hxxps://investors.mySo around 23% of the company owned by a hand full of investors and Directors. Second biggest investor being disclosed. I expect this to be received as a positive really because that means only 40m shares roughly on the open market. For a company that declared it had nearly 8m in the bank and close to breakeven. No debt I guess someone building a stake. If the company puts out a positive set of results all be it accounting for an expected slowdown in Covid Revenue we could see a shift to upward momentum. It’s always maintained a decent balance sheet and demonstrates it’s prudent with cash unlike companies like GDR that find themselves in need of diluting the company and destroying shareholder value. I do feel MHC is well run and not had market support but the Directors do need to extract the value by presenting a forward growth and expansion plan. No debt is a real bonus however profits can prove crucial. Surely closed period now or soon as results due shortly |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
